Saiama N. Waqar

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

March, 2025

Saiama N. Waqar

Jan 8, 2025, 11:37 | Blog

Aakash Desai: Sacituzumab govitecan continues to show promise as a 2-line treatment for extensive-stage SCLC

Aakash Desai, Assistant Professor at UAB O’Neal Comprehensive Cancer Center, shared on LinkedIn: "Sacituzumab govitecan…

Jan 4, 2025, 13:45 | Science

Jarushka Naidoo: Phase II TROPICS-03 trial: Sacituzumab Govitecan (TROP2 ADC) in 2L SCLC

Jarushka Naidoo, Thoracic Oncologist at the Beaumont Hospital Dublin (Ireland), shared a recent article by…

Aug 6, 2024, 11:29 | Insight

Lung-MAP Next Generation Sequencing Analysis of Advanced Squamous Cell Lung Cancers

Lung-MAP shared on LinkedIn: "Just out in Journal of Thoracic Oncology (JTO): Lung-MAP Next Generation…

All: 3 Posts: 1 - 100

'

Karen Knudsen has been appointed as the CEO of the Parker Institute for Cancer Immunotherapy

'

Highlights from ELCC 2025

'

FDA Approved Pluvicto (177Lu-PSMA-617) for Metastatic Castration-Resistant Prostate Cancer

'

Meet the New AACR Board of Directores for 2025-2028 Term

'

Do Artificial Sweeteners Cause Cancer? Myths and Facts

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023